Download video

Improving Quality of Life and Survival in Patients with MDS

432 views

OncLive

8 years ago

Improving Quality of Life and Survival in Patients with MDS

Improving Quality of Life and Survival in Patients with MDS

Improving Quality of Life and Survival in Patients with MDS
5:52
Improving Quality of Life and Survival in Patients with MDS
by OncLive
Quality of life concerns; living with MDS
1:56
Quality of life concerns; living with MDS
by The Patients' Channel
Quality of Life as Treatment Goal in MDS
28:38
Quality of Life as Treatment Goal in MDS
by HMP Education
Quality of life assessment and transfusion-free survival
27:43
Quality of life assessment and transfusion-free survival
by MDS Hub
Quality of Life in Transfusion-Dependent MDS
4:04
Quality of Life in Transfusion-Dependent MDS
by OncLive
Transplant Outcomes in Older Adults with MDS and AML 2021
57:15
Transplant Outcomes in Older Adults with MDS and AML 2021
by BMT InfoNet
Understanding QoL (Quality of life) in High-Risk MDS \& AML
1:02:31
Understanding QoL (Quality of life) in High-Risk MDS \& AML
by MDS UK Patient Support Group
MDS: QoL considerations
2:36
MDS: QoL considerations
by VJHemOnc – Video Journal of Hematology \& HemOnc
Blood transfusion thresholds and QoL in MDS patients
2:01
Blood transfusion thresholds and QoL in MDS patients
by VJHemOnc – Video Journal of Hematology \& HemOnc
The current standard of care for patients with lower-risk MDS
1:20
The current standard of care for patients with lower-risk MDS
by VJHemOnc – Video Journal of Hematology \& HemOnc
Aziz Nazha, MD: Personalized Approach Improves Survival Prediction in Patients With MDS
4:14
Aziz Nazha, MD: Personalized Approach Improves Survival Prediction in Patients With MDS
by DocWire
Improving Quality of Life for Leukemia Patients
7:11
Improving Quality of Life for Leukemia Patients
by Memorial Sloan Kettering Cancer Center
Debate: Hypomethylating agents are appropriate in lower-risk MDS - Only Use With Caution
20:13
Debate: Hypomethylating agents are appropriate in lower-risk MDS - Only Use With Caution
by HMP Education
Dr. David Steensma on MDS research | Dana-Farber Cancer Institute
2:13
Dr. David Steensma on MDS research | Dana-Farber Cancer Institute
by Dana-Farber Cancer Institute
Immunosuppressive therapy in myelodysplastic syndrome
2:28
Immunosuppressive therapy in myelodysplastic syndrome
by ecancer
Personalized Care in MDS: Integrating Innovative Treatments Into a Cohesive Patient Care Model
1:29:40
Personalized Care in MDS: Integrating Innovative Treatments Into a Cohesive Patient Care Model
by PeerView Oncology
A new set of treatment options for low-risk MDS
3:38
A new set of treatment options for low-risk MDS
by VJHemOnc – Video Journal of Hematology \& HemOnc
BMT CTN 1102: pre-transplantation QoL measures improve prognostication in HR-MDS
0:59
BMT CTN 1102: pre-transplantation QoL measures improve prognostication in HR-MDS
by VJHemOnc – Video Journal of Hematology \& HemOnc
Therapeutic Advancements in Myelodysplastic Syndromes: Essential Guidance for Nursing Practice
1:04:27
Therapeutic Advancements in Myelodysplastic Syndromes: Essential Guidance for Nursing Practice
by PeerView Oncology
Treatment Goals for Higher Risk MDS
7:26
Treatment Goals for Higher Risk MDS
by OncLive